m6A regulator expression profile predicts the prognosis, benefit of adjuvant chemotherapy, and response to anti-PD-1 immunotherapy in patients with small-cell lung cancer

Overview of attention for article published in BMC Medicine, November 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 4 X users

Readers on

mendeley: 16 Mendeley

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 117,488 followers.

RT @BMCMedicine: m6A regulator #Expression profile predicts the prognosis, benefit of adjuvant #chemotherapy and response to anti-PD-1 #imm…

Reply Repost Favourite

RT @BMCMedicine: m6A regulator #Expression profile predicts the prognosis, benefit of adjuvant #chemotherapy and response to anti-PD-1 #imm…

Reply Repost Favourite

m6A regulator #Expression profile predicts the prognosis, benefit of adjuvant #chemotherapy and response to anti-PD-1 #immunotherapy in patients with #SCLC Read it here: https://t.co/wFqkkOGIa0 https://t.co/nzbg8oqs8v

Reply Repost Favourite

New article: m(6)A regulator expression profile predicts the prognosis, benefit of adjuvant chemotherapy, and response to anti-PD-1 immunotherapy in patients with small-cell lung cancer https://t.co/MaArI2Ie82 #lungcancer #oncology https://t.co/dVyyBr6vSr

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.